Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 484K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Scheiffele, P. Articles by Ikonen, E. Search for Related Content PubMed PubMed Citation Articles by Scheiffele, P. Articles by Ikonen, E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Substance via MeSH Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/1998//795 $5.00
The Journal of Cell Biology, Volume 140, Number 4, , 1998 795-806

Caveolin-1 and -2 in the Exocytic Pathway of MDCK Cells

P. Scheiffele^*, P. Verkade^*, A.M. Fra, H. Virta^*, K. Simons^*, and E. Ikonen^*

^* Cell Biology Programme, European Molecular Biology Laboratory, D-69012 Heidelberg, Germany; and Department of Biological and Technical Research-Hospital San Raffaele, 20132 Milan, Italy

Abstract. We have studied the biosynthesis and transport of the endogenous caveolins in MDCK cells. We show that in addition to homooligomers of caveolin-1, heterooligomeric complexes of caveolin-1 and -2 are formed in the ER. The oligomers become larger, increasingly detergent insoluble, and phosphorylated on caveolin-2 during transport to the cell surface. In the TGN caveolin-1/-2 heterooligomers are sorted into basolateral vesicles, whereas larger caveolin-1 homooligomers are targeted to the apical side. Caveolin-1 is present on both the apical and basolateral plasma membrane, whereas caveolin-2 is enriched on the basolateral surface where caveolae are present. This suggests that caveolin-1 and -2 heterooligomers are involved in caveolar biogenesis in the basolateral plasma membrane. Anti–caveolin-1 antibodies inhibit the apical delivery of influenza virus hemagglutinin without affecting basolateral transport of vesicular stomatitis virus G protein. Thus, we suggest that caveolin-1 homooligomers play a role in apical transport.

CAVEOLIN-1, a 21–24-kD membrane protein, was originally isolated from two different sources: from trans-Golgi network–derived exocytic vesicles (hence its other name VIP21, vesicular integral membrane protein of 21 kD) (Kurzchalia et al., 1992), and from plasma membrane invaginations called caveolae (Rothberg et al., 1992). Caveolae can be internalized from the surface and the protein might cycle between different cellular compartments (Parton et al., 1994; Schnitzer et al., 1994), however, its functions are poorly understood thus far. Caveolin-1 plays an important structural role in forming caveolar invaginations on the plasma membrane (Fra et al., 1995), but as yet there are no studies addressing its function in the TGN. Caveolin-1 has two isoforms, - and β-derived from the use of two alternative transcription initiation sites, the latter starting with an internal methionine at position 32 (Scherer et al., 1995). It has an unusual topology, forming a membrane-embedded hairpin structure with both the amino and carboxyl termini in the cytoplasm (Dupree et al., 1993). Furthermore, it has been reported to form high molecular weight homooligomeric complexes (>10⁴ kD) that resolve into 200-, 400-, and 600-kD oligomers when analyzed by SDS-PAGE without boiling (Monier et al., 1995; Sargiacomo et al., 1995). Caveolin-1 has also been shown to bind tightly to cholesterol (Murata et al., 1995; Li et al., 1996b). The primary determinants of oligomerization are protein domains of caveolin-1, but cholesterol binding promotes oligomerization that is further stabilized by the attachment of palmitoyl chains to the carboxyl-terminal region (Monier et al., 1996). The oligomers isolated from tissues or cultured cells are insoluble in detergents, such as Triton X-100 or CHAPS at 4°C (Kurzchalia et al., 1992; Sargiacomo et al., 1993). Oligomers can also be produced from in vitro–synthesized caveolin-1 after translocation into microsomal membranes. However, these oligomers are Triton X-100 soluble (Monier et al., 1995).

Recently, a related protein having 38% sequence identity to caveolin-1 was isolated from caveolin-enriched membranes and termed caveolin-2 (Scherer et al., 1996). Caveolin-2 was coexpressed with caveolin-1 in all the tissues analyzed, being most abundant in adipocytes. The epitope-tagged and overexpressed caveolin-2 colocalized with caveolin-1 in fibroblasts, as judged by immunofluorescence microscopy. However, in contrast to caveolin-1, caveolin-2 was found to exist mainly as a monomer (Scherer et al., 1996).

MDCK epithelial cells are a well-characterized model system for studying polarized membrane trafficking, and are one of the sources from which caveolin-1 was first isolated (Kurzchalia et al., 1992). These cells can form polarized monolayers with distinct apical and basolateral surfaces. Sorting of proteins destined for the two plasma membrane domains takes place in the TGN where separate apical and basolateral vesicles form to deliver cargo to the correct destinations (Griffiths and Simons, 1986). In this paper we have analyzed the routing and biochemical characteristics of endogenous, newly synthesized caveolin-1 and -2 in MDCK cells. We provide evidence that the two caveolins can form homo- and heterooligomeric complexes in the ER, and that these complexes are modified during transport to the plasma membrane. We further demonstrate that large caveolin-1 complexes are present in apical transport vesicles. In contrast, smaller caveolin-1/-2 heterooligomers are routed to the basolateral membrane where caveolin-2 is enriched and caveolar structures are found. Apical but not basolateral exocytosis can be inhibited with caveolin-1 antibodies, suggesting that two different caveolin complexes function in TGN to surface transport.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Reagents
Unless otherwise stated, all chemicals were obtained from the sources described previously by Wandinger-Ness et al. (1990) and Ikonen et al. (1995). The polyclonal anti–caveolin-1 amino-terminal antibody has been characterized (Dupree et al., 1993) and the anti–caveolin-1 antibody designated N-20 was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). To generate anti–caveolin-2 antibodies, polyclonal sera were raised against a synthetic peptide using the residues DFGDLEQLADSGSDR of canine caveolin-2. Sera for biochemical experiments were affinity purified using a GST-His6–caveolin-2 fusion protein (see Fig. 1; Peränen, 1992). For immunofluorescence microscopy, sera were affinity purified on a column prepared by coupling the fusion protein to CNBr-activated– Sepharose 4B or a protein A–Sepharose CL-4B column, according to the manufacturer's instructions (Pharmacia Biotech, Inc., Piscataway, NJ). Antibodies were eluted at low pH (0.2 M glycine, pH 2.8). Molecular mass standards used in gradient centrifugation were from Sigma Chemical Co. (St. Louis, MO). Detergents were the following: SDS (Bio-Rad Laboratories, Hercules, CA), Triton X-100 (Serva, Heidelberg, Germany), CHAPS (Sigma Chemical Co.), and N-octyl-3-D-glucopyranoside (Calbiochem-Novabiochem, La Jolla, CA). Methyl-β-cyclodextrin was from Sigma Chemical Co. and lovastatin was from Merck, Sharp, and Dohme (Haar, Germany).

View larger version (46K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Caveolin-1 and -2 in MDCK cells. Anti–caveolin-1 immunoprecipitates were analyzed by 13% SDS-PAGE (A) and by 2D gel electrophoresis (B). For comparison, 2D gels of immunoisolated basolateral (C) and apical (D) vesicles are shown. – and β–caveolin-1 are marked by arrowheads. Caveolin-2 is marked by arrows. Filter-grown MDCK cells metabolically labeled with [35S]methionine were lysed and then caveolin was immunoprecipitated using anti– caveolin-1 amino-terminal antibodies. The samples were boiled in alkaline sample buffer before electrophoresis.

Cloning of Canine Caveolin-2 cDNA
For purification of canine caveolin-2, a detergent-insoluble fraction was prepared from floated MDCK cell membranes and fractionated by affinity chromatography on hydroxylapatite as described (Shevchenko et al., 1997). Caveolin-2 was isolated by two-dimensional (2D) gel electrophoresis and then tryptic peptides from 50 Coomassie-stained spots were subjected to Edman degradation. Total RNA was purified from MDCK cells using the RNeasy kit (QUIAGEN, Inc., Santa Clarita, CA). Oligo-dT and random primed cDNA generated with M-MLV reverse transcriptase (Promega Corp., Madison, WI) was amplified by PCR with synthetic oligonucleotides designed according to the human cDNA sequence (5'-ATGGACGACGACTCCTACAGCCACCA-3' and 5'-ACCATIARRCAIGTYTTIACRAANGGC-AT-3') yielding a 334-bp fragment. With this fragment, 360,000 clones of a ZAPII MDCK cDNA library were screened. 12 independent positive phages were isolated containing inserts of 1.5–2.3 kbp. Sequencing of the inserts revealed that none of the obtained clones contained the full-length cDNA, therefore, 5' RACE (GIBCO BRL, Gaithersburg, MD) was performed using synthetic oligonucleotides (5'-AACCCCTGCCGCGAAG-3' and 5'-AAGGCCATGGGCATCGCCAGGAGCAAC-3') for priming in reverse transcription and amplification, respectively. The obtained 5' end was then fused to the rest of the coding sequence. The obtained full-length canine caveolin-2 sequence is available from GenBank/EMBL/DDBJ accession number AF039223. A stable MDCK II cell line was established overexpressing caveolin-2 with a carboxy-terminal myc epitope. The tag was introduced by PCR and the cDNA was inserted in the expression plasmid pcDNA3 (Invitrogen, Carlsbad, CA). The DNA was transfected using electroporation and stable clones were selected with 0.5 mg/ml G418 (GIBCO BRL). The myc-tagged caveolin-2 was found in SDS-resistant oligomers to a similar extent as the endogenous protein.

Labeling of Cells and Caveolin Immunoprecipitation
For pulse-chase experiments, cells were starved for 30 min at 37°C in methionine-free medium before labeling with [³⁵S]methionine (500 µmCi/filter) for 7 min. The cells were then either transferred to ice-cold chase medium and lysed immediately, or chased at 20°C for 1 or 2 h or chased at 37°C for 1 or 2 h before lysis. A 2-h chase at 37°C gave results similar to a 1-h chase. In the cyclodextrin experiment (Scheiffele et al., 1997), cells were chased for 1 h at 37°C before adding 10 mM methyl-β-cyclodextrin, in chase medium containing 5 µM lovastatin and 50 mM Hepes, pH 7.4, to both sides of the filter and incubating with shaking for 1 h at 37°C. A metabolic labeling was carried out for 18 h with 100 µCi/filter [³⁵S]methionine. The compositions of the labeling and chase media have been described previously (Wandinger-Ness et al., 1990).

For immunoprecipitation, cells were solubilized on ice in 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.4% SDS, 0.2% Triton X-100 in the presence of protease inhibitors (chymostatin, leupeptin, antipain, and pepstatin at 25 µg/ml each) and phosphatase inhibitors (200 µM sodium vanadate, 50 mM sodium fluoride). Lysates were incubated overnight at 4°C with the respective antibody and recovered with protein A–Sepharose (Pharmacia Biotech, Inc.). The immunoprecipitates were washed five times with 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.1% SDS, 0.5% Triton X-100, and phosphatase inhibitors (see above) and twice with 50 mM Tris-HCl, pH 7.5, before separation by SDS-PAGE.

For [³²P], confluent MDCK cells from one 2.4-cm well of a six-well plate were washed twice with phosphate-free DME containing 0.1% FCS dialyzed against 20 mM Tris-HCl, pH 7.6, 137 mM NaCl (TBS).

After incubating for 50 min in this medium the cells were labeled for 3 h at 37°C with 500 µCi of [³²P]ATP in 1 ml of the same medium. Cells were lysed in 100 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1% Triton X-100, protease inhibitors, 2 mM sodium vanadate, and 50 mM sodium fluoride by incubating for 20 min at 37°C with intermittent vortexing. After spinning at 3,000 rpm in a microfuge (Eppendorf, Hamburg, Germany), the insoluble debris was discarded, the lysates precleared with protein A–Sepharose overnight at 4°C, and then precipitated with the anti–caveolin-1 antibody as described above. [³⁵S]methionine carried out overnight in an identical well, and other treatments performed in parallel with the [³²P] sample gave results similar to the steady-state [³⁵S]methionine and immunoprecipitation on filter-grown cells as described above. [³²P] and [³⁵S]methionine was also carried out in 3T3 L1 preadipocytes, yielding results similar to MDCK cells.

SDS-PAGE, 2D Gel Electrophoresis, and Western Blotting
Immunoprecipitates were solubilized either in standard SDS-PAGE sample buffer or in alkaline buffer (Monier et al., 1995). The samples were incubated for 30 min at 25°C or heated to 95°C for 5 min as detailed in the figure legends. When the samples were not heated, 200-, 400-, and 600-kD oligomers could be visualized by SDS-PAGE. The proteins were resolved either on 13% linear or 3–17% gradient polyacrylamide gels. To dissociate the oligomers for 2D gel electrophoresis, immunoprecipitates were heated at 95°C for 10 min in alkaline sample buffer (in the presence of 1 mM vanadate), precipitated with chloroform/methanol, and then incubated at 37°C for 30 min in the isoelectric focusing sample buffer (Bravo, 1984). Proteins were resolved as detailed by Wandinger-Ness et al. (1990) in two dimensions by IEF and SDS-PAGE based on the method of Bravo (1984).

For Western blotting, MDCK cells were lysed in the same buffer as for immunoprecipitations, incubated for 30 min at 25°C, and then proteins were separated on polyacrylamide gels. Proteins were transferred to a nitrocellulose membrane in 25 mM Tris-HCl, 190 mM glycine, and 20% methanol and after blocking and incubation with the respective antibodies detected with enhanced chemiluminescence (Amersham Corp.).

Isolation of Budded Vesicles from Semiintact Cells
A budded fraction was prepared essentially as described by Xu and Shields (1993) using a hypotonic swelling procedure to selectively disrupt the plasma membrane (Beckers et al., 1987). Briefly, confluent MDCK cells (passages 6–25) on 10-cm dishes infected with influenza virus (PR8) or VSV were pulse labeled with [³⁵S]methionine 3 h after infection and then the radiolabeled glycoproteins were accumulated in the TGN by a 20°C temperature block for 2 h. After washing the cells three times with ice-cold swelling buffer (10 mM Hepes [pH 7.2], 15 mM KCl) and incubation for 10 min on ice, cells were scraped in 3 ml of breaking buffer (50 mM Hepes [pH 7.2], 90 mM KCl), pelleted at 800 g, and then washed once with breaking buffer. Cells were resuspended in GGA buffer (25 mM Hepes, [pH 7.4], 38 mM potassium gluconate, 38 mM potassium glutamate, 38 mM potassium aspartate, 2.5 mM MgCl₂, 0.5 mM CaCl₂, 1 mM DTT, and protease inhibitors) and complemented with ATP regenerating system, 0.1 mM GTP, 1 mg/ml rat liver cytosol. After incubation for 45 min at 37°C, cells were pelleted in a microfuge at 6,000 g and the budded fraction was either analyzed directly by Western blotting or fluorography, or the sample was adjusted to 30% Optiprep (Nycomed Pharma, Oslo, Norway), overlayered with 25% Optiprep, 5% Optiprep, all in 10 mM Hepes (pH 7.4), 140 mM KCl, 2 mM EGTA, 1 mM DTT. The samples were centrifuged for 3 h at 55,000 rpm in a TLS55 rotor (Beckman, Munich, Germany) and then the vesicular fraction recovered from the 25%/5% interphase was analyzed by Western blotting, fluorography, or electron microscopy.

To determine release of the trans-Golgi marker sialyltransferase from cells, a cell line expressing VSV-G–tagged human sialyltransferase was established and protein was detected by blotting with the monoclonal antibody P5D4 (Kreis, 1986) or immunoprecipitation.

Immunoisolation of Apical and Basolateral Vesicles
Immunoisolation of apical and basolateral vesicles from perforated MDCK cells was carried out as detailed by Wandinger-Ness et al. (1990). Briefly, filter-grown MDCK cells were labeled overnight with [³⁵S]methionine, infected with either influenza virus or VSV, and viral proteins were accumulated in the TGN by a 20°C block. The cells were perforated and membranes released during a 37°C incubation and then were floated on a sucrose gradient. Apical and basolateral vesicles were immunoisolated on cellulose fibers from the floated membrane fraction using antibodies directed against influenza virus hemagglutinin (HA) and VSV-G, respectively. Proteins were recovered from the fibers in 0.4% SDS, 0.2% Triton X-100 in TNE, and then loaded on a 5–30% sucrose gradient (see below). Caveolin complexes were immunoprecipitated from the fractions with anti–caveolin-1 antibodies and the radioactivity recovered in each fraction was counted in a liquid scintillation counter (Wallac 1410; Pharmacia Biotech, Uppsala, Sweden).

Sucrose Gradient Centrifugation
Cell lysates or immunoisolated vesicles (300 µl) in 0.4% SDS, 0.2% Triton X-100, and protease inhibitors (see above) were loaded onto a linear 5–30% sucrose gradient in 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.4% SDS, 0.2% Triton X-100. After centrifugation in a SW60 rotor (Beckman) for 16 h at 45,000 rpm, 500 µl fractions were collected from the top. For Western blot analysis, proteins were TCA precipitated or immunoprecipitated with anti–caveolin-1 antibodies in the case of labeled samples. Proteins were resolved on gradient polyacrylamide gels.

CHAPS Extraction
After pulse-chase labeling, the cells were scraped on ice in 500 µl of 20 mM CHAPS in 50 mM Tris-HCl, pH 7.0, 100 mM NaCl, 1 mM EDTA (TNE) in the presence of protease and phosphatase inhibitors (see above). After resuspension 10 times with a 1-ml pipet tip, they were incubated on ice for 30 min, and CHAPS-insoluble material was pelleted by centrifugation in a TLA45 rotor (Beckman) for 30 min at 45,000 rpm and 4°C. The supernatant was collected and the pellet resuspended in CHAPS extraction buffer. 4 vol of 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.5% SDS, and protease and phosphatase inhibitors (see above) were added and caveolin complexes immunoprecipitated.

In Vitro Transport Assays
The transport of VSV-G and HA in streptolysin O (SLO)-permeabilized MDCK cells was carried out exactly as described previously (Pimplikar et al., 1994; Ikonen et al., 1995; for review see Lafont et al., 1995). Briefly, to measure TGN-to-surface transport, filter-grown MDCK cells were infected with VSV or influenza virus, viral proteins were pulse labeled with [³⁵S]methionine, and then chased to the TGN using a 20°C incubation. The apical or basolateral cell surface was then permeabilized with SLO, the endogenous cytosol was depleted, and transport to the intact surface reconstituted. The amount of viral proteins reaching the surface was measured by trypsinization (HA) or surface immunoprecipitation (VSV-G). To measure transport from the ER, the 20°C-chase was omitted and SLO permeabilization was carried out immediately after pulse labeling. The amount of viral proteins reaching the Golgi complex was determined by endoglycosidase H digestion. The anti–caveolin-1 amino-terminal antibody N-20 was used at a final concentration of 10 µg/ml. Before raising the temperature to 37°C to initiate transport, the cells were incubated for 30 min at 4°C with cytosol ± antibody and an ATP regenerating system. Quantitation of viral polypeptides resolved by SDS-PAGE was done with a Phosphor Imager (Molecular Dynamics, Sunnyvale, CA). Transport without added cytosol was defined as 0% and transport in the presence of cytosol as 100%, being 2.5–4.5-fold higher than without cytosol. The values obtained in the presence of antibodies were expressed as a percentage of those given without antibody addition. All transport assays were performed in triplicate and each condition was tested at least twice.

Immunofluorescence Microscopy
Filter-grown, confluent MDCK cells were rinsed once in PBS and then fixed for 10 min in 4% paraformaldehyde/PBS. The filters were rinsed briefly in PBS, cut from the holder, and then incubated for 30 min in 200 mM glycine/PBS. They then were incubated for 10 min in 0.1% Triton X-100/PBS and nonspecific antibody binding was blocked by incubating for 10 min in PBS containing 0.2% cold-water fish skin gelatin (PBS-G). The filter pieces were incubated for 2 h with either affinity-purified rabbit anti–caveolin-1 antibodies (N20) diluted 1:25 or rabbit anti–caveolin-2 antibodies diluted 1:10 in PBS-G. After extensive rinsing (more than six times at 5-min each) the filterpieces were incubated for 1 h at 37°C with fluorescein thiocyanate coupled anti-rabbit antibodies in PBS G. After extensive rinsing in PBS, the filter pieces were embedded in 50% glycerol, 100 µg/ml 1,4-diazobi-cyclo(2,2,2)-octane in PBS, and then examined under a confocal scanning light microscope (LSM410; Carl Zeiss, Inc., Thornwood, NY).

Immunoelectron Microscopy
Filter-grown confluent MDCK cell were rinsed once in PBS and fixed for 10 min in 4% paraformaldehyde/PBS. Triangular filter pieces in PBS were progressively infiltrated with gelatin at 37°C to a final concentration of 10%. They were put on ice and infiltrated with 2.1 M sucrose. The filter pieces were put on top of a cryosectioning stub and frozen in liquid nitrogen. Ultrathin cryosections were collected on grids and incubated face-down in PBS for 30 min at 37°C to dissolve the gelatin. The grids were transferred for 30 min to 10% FCS in PBS and then incubated for 1 h with affinity-purified rabbit anti–caveolin-1 antibodies (N20) diluted 1:20 or rabbit anti–caveolin-2 antibodies diluted 1:10 in 5% FCS in PBS. The grids were rinsed in PBS and incubated for 20 min with protein A–coupled 10-nm gold particles in 5% FCS in PBS. The grids were rinsed extensively with PBS and tridistilled water and then incubated for 10 min with 0.3% uranyl acetate, 1.8% methylcellulose in tridistilled water on ice. Excess fluid was removed and then the grids were air-dried. Sections were examined under a Zeiss EM1OC transmission electron microscope.

For immunolabeling of isolated vesicles, small droplets (1–2 µl) of the vesicle preparation were put on top of formvar and carbon-coated copper grids for 5 min. They were then fixed on top of a drop of 4% paraformaldehyde (PFA) in PBS for 5 min. After blocking with 200 mM glycine in PBS for 10 min and a 5-min wash in PBS containing 0.5% BSA and 0.2% cold-water fish skin gelatin (PBG), the grids were incubated for 15 h with the first primary antibody in PBG at 4°C. After a 3–5-min rinse in PBG, the grids were incubated with protein A–coupled 15-nm gold particles in PBG for 1 h and then rinsed in PBS. In a second (5 h at room temperature) and third (15 h at 4°C) round of immunoincubation, the sequence of labeling was repeated from the fixation to the washing in PBS. In the second and third round, protein A coupled to 10- and 5-nm gold particles were used, respectively. After the third round of labeling, the grids were rinsed in tridistilled water and then incubated for 5 min on ice in 0.3% uranyl acetate, 1.8% methylcellulose in tridistilled water. The excess fluid was removed and the grids were air-dried. Controls included the omission (of combinations) of primary antibodies after which the accompanying gold particles were not detected. For quantitations, routinely gold particles on 40 individual vesicles were counted. Vesicles were considered positive for the viral marker proteins when they contained at least two particles. In individual experiments similar results were obtained independently, in which the order of the antigens was labeled with the antibodies.

	Results

Top Abstract Materials and Methods Results Discussion References

 
A New Protein Coprecipitates with Caveolin-1 Antibodies
Antibodies raised against the first 20 amino-terminal amino acids of caveolin-1 recognize a single band of 24-kD by Western blotting, corresponding to the isoform of caveolin-1 (Dupree et al., 1993). However, these antibodies immunoprecipitate proteins that are resolved as two bands of 21- and 24-kD, respectively, in SDS-PAGE (Dupree et al., 1993, Fig. 1 A). So far, these bands have been thought to represent – and β–caveolin-1 (Monier et al., 1995). Surprisingly, when the immunoprecipitates were analyzed on a 2D gel, other spots in addition to the ones known to correspond to – and β–caveolin-1 were revealed. By far, most abundant was a cluster of spots that corresponded in size to β–caveolin-1 but had a more acidic isoelectric point (Fig. 1 B). When comparing this pattern to the 2D gel maps of immunoisolated apical and basolateral transport vesicles, we found that this elongated pattern corresponded exactly to a protein heavily enriched in basolateral transport vesicles that was designated B12 (Fig. 1, C and D; Wandinger-Ness et al., 1990).

Cloning of Canine Caveolin-2 cDNA
To identify this protein potentially associating with caveolin-1, a detergent-insoluble fraction of floated MDCK cell membranes was prepared, separated by affinity chromatography on hydroxylapatite as described (Shevchenko et al., 1997), and the protein was isolated from 2D gels for microsequencing. The obtained peptide sequences (X-S-A-V-D-F-G-X-L-E-Q and X-F-S-S-V-X-L-Q/L-V, see Fig. 2 D) suggested that the protein was caveolin-2. A partial canine caveolin-2 cDNA was then amplified using degenerate oligonucleotides derived from the human caveolin-2 cDNA sequence (Scherer et al., 1996) and used to screen a ZAPII MDCK cDNA library. 5'-RACE revealed that the ATG corresponding to the published initiator methionine in the highly homologous human caveolin-2 was preceded by an in-frame methionine, 13 amino acids further upstream (Fig. 2 D). The sequences flanking this ATG conform better to the Kozak consensus than those around the downstream ATG, suggesting that it may be used as the preferential initiator site. Moreover, database searches revealed a human expressed sequence tag (THC180343; GenBank/EMBL/DDBJ accession number AA367026) that also carries the upstream start codon. As the amino-terminal part was most divergent between caveolin-1 and -2, we used a peptide containing amino acids 26–40 as an immunogen to raise canine caveolin-2–specific antibodies (Fig. 2 D). In Western blotting this antibody was found to recognize two proteins of 19- and 21-kD, both distinct from –caveolin-1 (Fig. 2, A and B). On 2D gels, the elongated group of spots representing B12 was detected (Fig. 2 C). In addition, the caveolin-2 antibodies cross-reacted with a cluster of spots of similar shape but of smaller size (19 kD, Fig. 2 C). These were found to correspond to minor spots beneath the original band cut for microsequencing (refer to Fig. 1 B). Based on the sequence information, it is likely to represent the product of a transcript using methionine 14 as an alternative, less favored site for initiation. Clearly, the anti–caveolin-2 antibodies were specific for these two rows of spots and did not cross-react with – and β–caveolin-1.

View larger version (63K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Specificity of the anti–caveolin-2 antibody. A MDCK cell lysate separated by SDS-PAGE (A and B) or by 2D gel electrophoresis C was analyzed by Western blotting. Blots were probed with anti–caveolin-1 amino-terminal antibodies (A) or with anti–caveolin-2 antibodies (B and C). The two spots identified in C correspond to two clusters of spots detected in the 2D gel of [35S]methionine and immunoprecipitated samples (refer to Fig. 1). The larger cluster has the same molecular weight as the spot cut for microsequencing. The 5' cDNA sequence of canine caveolin-2 and the encoded amino acids are aligned with the human expressed sequence tag containing the upstream ATG codon (D). The sequence of a tryptic peptide is underlined. The peptide used to raise anti–caveolin-2 specific antibodies is indicated by a box.

View larger version (90K): [in this window] [in a new window] [Download PPT slide]   Figure 3 Caveolin-2 forms high molecular weight complexes. Western blotting using anti–caveolin-1 antibody N-20 or anti– caveolin-2 antibodies was performed after separating MDCK cell lysate on SDS-PAGE without boiling (A). Alternatively, the cell lysate was first fractionated by sedimentation velocity in a 5–30% sucrose gradient, and TCA proteins precipitated from the fractions were separated by 13% SDS-PAGE after boiling in alkaline sample buffer (B). The migration of molecular mass standards in the gradient is indicated.

View larger version (39K): [in this window] [in a new window] [Download PPT slide]   Figure 4 Composition of the caveolin oligomeric complex at steady state. MDCK cells were labeled overnight with [35S]methionine, proteins were immunoprecipitated with caveolin-1 (top) or -2 antibodies (bottom), and then analyzed by 1- (left) or 2D gel electrophoresis (right) after boiling in alkaline sample buffer. The anode is to the right. For quantification of the relative amounts of caveolin-1 and -2, gels were scanned by a Phosphor Imager.

Protein Composition of the Complexes.
The results shown in Fig. 5 suggest that a heterooligomeric complex is formed already in the ER, as both anti–caveolin-1 (Fig. 5, A–C) and -2 antibodies (data not shown) brought down both of the proteins in all conditions tested. The relative proportions of the two proteins did not seem to change significantly during biosynthetic transport, except for slightly more caveolin-2 being precipitated without chase (in the ER) than in the other conditions (compare Fig. 5 A to B and C).

View larger version (63K): [in this window] [in a new window] [Download PPT slide]   Figure 5 Analysis of the caveolin complex by 2D gel electrophoresis during biosynthetic transport. MDCK cells were pulse labeled with [35S]methionine for 7 min and either lysed immediately (A), chased for 1 h at 20°C (B) or chased for 1 h at 37°C (C) before lysis. Alternatively, cells were labeled for 3 h with [32P]ATP (D). The caveolin complex was immunoprecipitated by anti–caveolin-1 antibodies and then analyzed on 2D gels.

Size of the Complexes.
To monitor changes of the complex sizes, pulse-labeled proteins were subjected to fractionation in the SDS–Triton X-100 sucrose gradient followed by immunoprecipitation with anti–caveolin-1 antibodies. The newly synthesized caveolins were monomeric (Fig. 6 A, fractions 2 and 3), but a sizeable fraction had already oligomerized forming a SDS–Triton X-100 stable complex of 200 kD (Fig. 6 A, fractions 5 and 6). Taking into account the inefficient precipitation of the monomers in the ER, a cautious quantitative assessment would be that in the ER at least ten times more of the protein exists as a monomer than as oligomer. Nevertheless, oligomerization obviously starts early in the biosynthetic route. When the proteins were chased for 1 h at 20°C, i.e., when most of the newly synthesized proteins resided in the Golgi apparatus, the caveolin complex increased in size, peaking at 400-kD with some already extending to the 600-kD range (Fig. 6 B). When performed at 37°C, most of the protein was chased to the cell surface; the caveolin oligomers matured further to higher molecular weight complexes, reaching the size range of the very large structures detected at steady state (Fig. 6 C). It is noteworthy that the choice of detergent in the gradient is critical to observe the size changes. N-octyl-3-D-glucopyranoside (octylglucoside) has previously been used in comparable size fractionation schemes and reported to detect oligomers between 200– 400-kD, irrespective of the conditions (Li et al., 1996b; Monier et al., 1996). In our experience, when SDS and Triton X-100 were replaced with octylglucoside, a similarly sized 200–400-kD oligomer was detected either in the ER or on the plasma membrane (data not shown). Therefore, the observed complex sizes do not necessarily reflect the molecular weight of the oligomers in vivo; however, they clearly demonstrate changes in size and nature of the complexes during biosynthetic transport. The maturation is likely to be achieved not only by protein–protein interactions, but might also be influenced by the lipid environment. This could explain why the choice of detergent and its capability to dissociate or preserve such protein–lipid complexes is critically influencing the resolved complex sizes.

View larger version (15K): [in this window] [in a new window] [Download PPT slide]   Figure 6 Size of the caveolin oligomeric complexes during biosynthetic transport and after cyclodextrin treatment. Filter-grown MDCK cells were pulse labeled for 7 min with [35S]methionine and then chased as indicated in A, B, and C. When cyclodextrin was added (+ CD), MDCK cells, pulsed for 7 min with [35S]methionine and chased for 1 h at 37°C, were treated for an additional 1 h at 37°C in the presence of 10 mM methyl-β-cyclodextrin as detailed in Materials and Methods. The lysates were fractionated by sedimentation velocity gradient centrifugation in 5–30% sucrose and caveolin immunoprecipitated from the fractions using anti– caveolin-1 amino-terminal antibodies. The intensities of the bands resolved by SDS-PAGE (containing caveolin-1 and -2) were scanned by a Phosphor Imager. The percentage of caveolin in each fraction is presented as bars.

Phosphorylation of the Complexes.
One striking observation from the 2D gel analysis of the caveolin complexes is that the number of spots corresponding to caveolin-2 increases during transport to the cell surface, with one extra, more acidic spot in the Golgi complex (Fig. 5 B) and two after 1 h at 37°C (delivery to the cell surface) (Fig. 5 C). Furthermore, this modification is extensive at steady state, producing up to four adjacent spots of the longer and three of the shorter form of caveolin-2 (Fig. 4). We assumed that these modifications causing an increase in negative charge without changing the apparent molecular weight could be phosphorylations, and therefore, we performed metabolic labelings with [³²P]ATP in parallel with [³⁵S]methionine. After [³²P] and immunoprecipitation with anti–caveolin-1, antibodies samples were separated on 2D gels. This analysis showed that in steady-state conditions, caveolin-2 is indeed heavily phosphorylated, whereas caveolin-1 is not (Fig. 5 D).

Detergent Solubility.
Caveolin-1 is known to be insoluble in the detergents Triton X-100 and CHAPS at 4°C, both in TGN-derived transport vesicles and in plasma membrane caveolae, whereas it is soluble when inserted into microsomes in vitro (Kurzchalia et al., 1992; Melkonian et al., 1995; Monier et al., 1995). To find out when this change occurs during biosynthetic transport, we analyzed the solubility of the caveolin complexes during a pulse-chase experiment. The oligomer was found to be entirely soluble immediately after the pulse labeling, and two-thirds of it still remained soluble after a 1-h chase at 20°C (Fig. 7). When the chase at 20°C was extended to 2 h, three-fourths of the complex had become CHAPS insoluble. If the protein was allowed to proceed along the biosynthetic route at 37°C, a 1-h chase was sufficient to convert it to a form resisting CHAPS solubilization as efficiently as the protein did at steady state (90% being CHAPS insoluble). Similar changes in the detergent solubility of the caveolin complex were observed when Triton X-100 was used at 4°C instead of CHAPS (data not shown). These data suggest that only after reaching the Golgi complex do caveolins become increasingly resistant to detergent extraction.

View larger version (62K): [in this window] [in a new window] [Download PPT slide]   Figure 7 Detergent solubility of the caveolin complexes during biosynthetic transport. MDCK cells were pulsed for 7 min with [35S]methionine and then chased. Cells were lysed in 20 mM CHAPS in TNE and the caveolin complex was immunoprecipitated from the supernatant (S) and the pellet (P) and then analyzed by 3–17% SDS-PAGE after boiling. Note that the complex is precipitated increasingly efficiently during the chase. The autoradiograph had to be exposed longer to detect pulse-labeled caveolin in the ER (no chase, data not shown).

View larger version (31K): [in this window] [in a new window] [Download PPT slide]   Figure 8 Size of the caveolin complexes in immunoisolated apical and basolateral transport vesicles. Apical and basolateral vesicles were isolated from virally infected MDCK cells as described in Materials and Methods. The immunoisolated vesicle preparations were fractionated by sedimentation velocity centrifugation and the caveolin complex in each fraction immunoprecipitated using anti–caveolin-1 antibodies. The radioactivity recovered from each fraction is indicated.

View larger version (55K): [in this window] [in a new window] [Download PPT slide]   Figure 9 Electron micrographs of TGN-derived vesicles labeled for influenza virus HA (15-nm gold; A) or VSV-G (15-nm gold; B and C) and caveolin-1 (10-nm gold) and caveolin-2 (5-nm gold). The scale bar in C represents 100 nm.

View larger version (43K): [in this window] [in a new window] [Download PPT slide]   Figure 10 Confocal immunofluorescence microscopy of caveolin-1 and -2 in filter-grown MDCK cells. The cells were labeled with anti–caveolin-1 (A) or -2 antibodies (B and C). Using the confocal microscope, z-sections were taken to show basolateral and apical staining. They were chosen such that the intracellular staining was hardly visualized. C shows an x, y-section taken from the region located above the nucleus (B). Bar, 5 µm.

View larger version (112K): [in this window] [in a new window] [Download PPT slide]   Figure 11 Electron micrographs showing the distribution of caveolin-1 (A and B) and -2 (C) in polarized MDCK cells. In B and C two opposing lateral membranes are shown. Caveolin-1 is present at the apical membrane (A) and at the basolateral membrane (B), where it is mainly present in caveolae (arrows). Caveolin-2 is mainly at the basolateral plasma membrane and its caveolar invaginations (C). A little further from the plasma membrane, caveolin-2 is associated with a vesicular profile (arrowhead), which resembles a caveolar profile deeper in the cell (C). Bar, 100 nm.

View larger version (13K): [in this window] [in a new window] [Download PPT slide]   Figure 12 Effect of anti– caveolin-1 antibodies on ER-to-Golgi (E–G), basolateral (BL), and apical (AP) transport. Anti–caveolin-1 antibody N-20 (10 µg/ml) was added to SLO-permeabilized MDCK cells, and then the transport of HA from the ER-to-Golgi complex or from the TGN to the apical surface or the transport of VSV-G from the TGN to the basolateral surface was measured. Transport is expressed as percentage of cytosol-dependent transport obtained in the absence of added antibody.

	Discussion

Top Abstract Materials and Methods Results Discussion References

Another fact that has previously escaped attention is that caveolin-2 exists in two forms. Like caveolin-1, caveolin-2 seems to use alternative translation initiation sites to produce and β isoforms. In caveolin-2, the longer alpha form is clearly more abundant, whereas the and β isoforms of caveolin-1 are equally prevalent.

Biosynthetic Maturation of the Caveolin Complex
One of the aims of this work was to analyze the changes taking place in the physical state of the caveolins during their passage from the ER to the cell surface. Earlier work has led to the following findings: a high molecular weight oligomer forms already in the ER and an oligomeric structure is maintained when the protein complex is transported along the biosynthetic route. Caveolin isolated from tissues, which represents the steady-state distribution of the protein in the TGN and caveolae, also exists as a large complex. This oligomer is detergent-insoluble and binds cholesterol (Monier et al., 1995; Murata et al., 1995). The caveolin–cholesterol complex is a key structural element in the formation of caveolae and is also potentially important in the organization of glycosphingolipid-cholesterol microdomains (rafts) involved in protein, and lipid sorting (Fra et al., 1995; Parton and Simons, 1995; Ikonen and Simons, 1997). Because neither caveolae nor rafts exist in the ER, the caveolin complex should change its behavior during intracellular transport. We now have systematically analyzed the biochemical characteristics of the caveolin oligomers in pulse-chase experiments and found the following changes.

First, although caveolin oligomers are partially formed early in the biosynthetic route, they increase in size on their way to the cell surface. Monomeric forms can also be detected in the ER (although accurate quantitation of the ratios between monomer and oligomer is not possible because the monomer is immunoprecipitated less efficiently). We used velocity sedimentation in SDS–Triton X-100 sucrose gradients to follow the changes during maturation of the caveolin complex. We found that the newly synthesized oligomer migrates as a 200-kD complex under these conditions. After 1 h at 20°C, the structures are between 200–400-kD and after 1 h at 37°C their size increases even further. Second, the complex becomes gradually detergent-insoluble from a completely soluble ER form to an insoluble form after transport to the Golgi complex. Third, caveolin-2 was found to become modified by the addition of increasing numbers of phosphate groups, the most extensive phosphorylation being found at steady state and therefore likely to be related to the trafficking of the complex between the TGN and the cell surface. Caveolin-1, on the other hand, was not phosphorylated under these conditions, although the protein can function as a substrate for kinases (Glenney and Soppet, 1992; Mastick et al., 1995; Li et al., 1996a). Fourth, the antibody reactivity of the complex changes during the chase period. There is not only a difference in the immunoprecipitation efficiencies between the monomeric and oligomeric forms, but also between different sizes of oligomers; the bigger the oligomer the more easily it is brought down by the anti–caveolin-1 amino-terminal antibody (Fig. 5). The same is true for the anti–caveolin-2 amino-terminal antibody (data not shown). Interestingly, we found that an anti–caveolin-1 carboxy-terminal antibody failed to immunoprecipitate the mature complex. However, this antibody recognized the ER form of the oligomer equally effectively as the amino-terminal antibody (data not shown). Similarly, the myc epitope that we introduced in the carboxy terminus of caveolin-2 is also less acccessible at the plasma membrane (data not shown), and antibodies against the carboxy terminus of caveolin-1 fail to detect the protein on the cell surface (Dupree et al., 1993). This suggests that a carboxy-terminal epitope available for antibody recognition in the ER becomes hidden during maturation of the complex. This is in agreement with the report that the carboxy terminus of caveolin is involved in oligomerization (Song et al., 1997). Also, palmitoylation of cysteine residues in the carboxy-terminal domain might interfere with antibody recognition (Dietzen et al., 1995).

Specialized Complexes of Caveolins Exist in the Apical and Basolateral Traffic Routes
These data demonstrate that the newly synthesized caveolins undergo dramatic changes during their transport to the cell surface. However, the most startling finding was the preferential routing of caveolin-2 to the basolateral cell surface as judged by its enrichment in basolateral carriers and its localization on the basolateral plasma membrane domain. Thus, the distributions of caveolin-1 and -2 are different over the polarized cell surfaces, caveolin-1 being present on both the apical and the basolateral sides. Our biochemical data and the electron microscopy analysis of apical and basolateral vesicles suggests that heterooligomers of caveolin-1 and -2 are incorporated into the basolateral transport vesicles in the TGN, whereas caveolin-1 homooligomers are included into the apical vesicles and transported to the apical plasma membrane domain. This notion is in accordance with our quantitation of the stoichiometry of the two proteins. Caveolin-1 was more abundant than caveolin-2 and caveolin-2 antibodies failed to coprecipitate caveolin-1 quantitatively. Moreover, we provided biochemical evidence for two differentially behaving caveolin oligomers. Size fractionation of the apical and basolateral caveolin complexes from immunoisolated vesicles revealed that the apical complexes formed larger oligomers than the basolateral ones. This, together with the fact that the >600-kD complexes contained less caveolin-2 (Fig. 3), further supports the presence of caveolin-1 oligomers in the apical vesicles. Finally, we found that apical protein transport can be disturbed by the addition of caveolin-1 antibodies, as reflected by reduced apical delivery of HA, whereas the transport of VSV-G protein recruited to basolateral vesicles occurred normally. Transport of HA was, however, not inhibited by the antibody earlier in the biosynthetic route, as ER-to-Golgi transport was not affected.

Working Model for the Differential Roles of Caveolin-1 and -2 in MDCK Cells
Based on these results we envisage caveolins-1 and -2 to participate in the two post-Golgi membrane traffic routes in MDCK cells as follows. The apical vesicles and the apical plasma membrane domain contain mostly caveolin-1 in a homooligomeric complex. The basolateral vesicles and the basolateral plasma membrane domain, on the other hand, contain heterooligomers of caveolin-1 and -2. The putative homooligomers of caveolin-1, formed in the ER, polymerize to larger structures by interactions with sphingolipid–cholesterol raft components during the formation of apical transport vesicles. How the heterooligomers of caveolin-1 and -2 become excluded from the apical vesicles and included in the basolateral carriers is an open question. They could become bound to another protein with basolateral sorting determinants, with binding possibly regulated by phosphorylation of caveolin-2.

One problem arising from the postulated differential sorting of caveolin-1 and -2 complexes concerns the biogenesis of caveolae. Caveolae are present in many cell types but in MDCK epithelial cells they are observed only on the basolateral but not on the apical cell surface (Fig. 11 and Parton, R.G., personal communication). On the other hand, earlier work has demonstrated that the overexpression of caveolin-1 is sufficient to trigger caveolar formation in cells normally lacking both caveolin-1 and caveolae (Fra et al., 1995; Li et al., 1996c). Why then do not the caveolin-1 complexes on the apical surface form caveolae? One possibility is that caveolae normally are formed by caveolin heterooligomers in which the phosphorylation of caveolin-2 may somehow lower the concentration necessary for caveolar assembly. In this case, strong overexpression of caveolin-1 might allow formation of caveolae that would not be fully functional. Alternatively, functional caveolae could be generated either by one or a combination of several caveolin types. Additional factors on the apical membrane could also be hindering the generation or maintenance of caveolae. Although this problem remains to be explored, it seems most likely from our results that heterooligomers of caveolin-1 and -2 become engaged in caveolar formation upon arrival to the basolateral cell surface.

What then is the function of the caveolin-1 homooligomers included in the apical vesicles? The most likely explanation is that caveolin-1 is used to organize lipid–raft microdomains in which rafts cluster to function as platforms for apical transport. The direct association of membrane proteins with rafts depends on cholesterol (Scheiffele et al., 1997; Simons and Ikonen, 1997), and the cholesterol-binding protein caveolin-1 might polymerize in the TGN to organize an apical patch. Importantly, it has been demonstrated that cholesterol depletion from cells inhibits apical transport (Keller, P., and K. Simons, manuscript submitted for publication) highlighting the importance of protein– lipid interactions for the apical pathway.

In conclusion, our data offer the first indications of the existence of functionally specialized complexes of caveolins. Moreover, they suggest that in addition to caveolar formation, caveolins can be involved in exocytic transport. However, the presumptive function of caveolin-1 in apical transport will require further studies. From work on other epithelial cell types lacking caveolin-1 (FRT and Caco-2 cells; Zurzolo et al., 1994; Mirre et al., 1996), we must conclude that caveolin-1 cannot be a general factor for apical sorting and delivery. Future research will have to clarify how the molecular machinery responsible for transporting sphingolipid–cholesterol rafts and their associated proteins is constructed in different cell types.

Submitted:

We thank members of the Simons lab for critical support, K. Ekroos and S. Brendel for expert technical assistance, W. Huttner (Universität Heidelberg, Heidelberg, Germany) for a critical reading of the manuscript, K. Ashman for peptide sequencing, M. Zerial for the ZAP library, J. Lanoix for rat liver cytosol, S. Bhakdi (Universität Mainz) for the generous supply of SLO, A. Puolasmaa (MSD-Finland) for the kind gift of lovastatin, and Anton G. Rietveld (European Molecular Biology Laboratory) for the help with cholesterol determinations.

This work was financially supported by the Academy of Finland, Commission of the European Communities, Theleton, and SFB 352.

E. Ikonen's present address is Dept. of Biochemistry, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland.

Address all correspondence to K. Simons, Cell Biology Programme, European Molecular Biology Laboratory, Meyerhofstrasse 1, Postfach 10 2209, D-69012 Heidelberg, Germany. Tel.: (49) 622-138-7334. Fax: (49) 622-138-7512.

1. Abbreviations used in this paper: 2D, two-dimensional; HA, influenza virus hemagglutinin; SLO, streptolysin-O; VSV-G, vesicular stomatitis virus glycoprotein.

	References

Top Abstract Materials and Methods Results Discussion References

 

Beckers CJM, Keller DS & Balch WE. Semi-intact cells permeable to macromolecules: Use in reconstitution of protein transport from the endoplasmatic reticulum to the Golgi complex, Cell, 1987, 50, 523–534.[Medline]

Bravo, R. 1984. Two-dimensional Gel Electrophoresis: A Guide for the Beginner. In Two-dimensional Gel Electrophoresis of Proteins. J.E. Celis and R. Bravo, editors. Academic Press Inc., Orlando, FL. 3–36.

Dietzen DJ, Hastings WR & Lublin DM. Caveolin is palmitoylated on multiple cystein residues, J Biol Chem, 1995, 270, 6838–6842.[Abstract/Free Full Text]

Dupree P, Parton RG, Raposo G, Kurzchalia TV & Simons K. Caveolae and sorting in the trans-Golgi network of epithelial cells, EMBO (Eur Mol Biol Organ) J, 1993, 12, 1597–1605.[Medline]

Fra AM, Williamson E, Simons K & Parton RG. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae, J Biol Chem, 1994, 269, 30745–30748.[Abstract/Free Full Text]

Fra AM, Williamson E, Simons K & Parton RG. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin, Proc Natl Acad Sci USA, 1995, 92, 8655–8659.[Abstract/Free Full Text]

Glenney JR & Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts, Proc Natl Acad Sci USA, 1992, 89, 10517–10521.[Abstract/Free Full Text]

Griffiths G & Simons K. The trans-Golgi network: sorting at the exit site of the Golgi complex, Science, 1986, 234, 438–443.[Abstract/Free Full Text]

Ikonen E, Tagaya M, Ullrich O, Montecucco C & Simons K. Different requirements for NSF, SNAP, and Rab proteins in apical and basolateral transport in MDCK cells, Cell, 1995, 81, 571–580.[Medline]

Kreis TE. Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis glycoprotein block its transport to the cell surface, EMBO (Eur Mol Biol Organ) J, 1986, 5, 931–941.[Medline]

Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M & Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi network–derived transport vesicles, J Cell Biol, 1992, 118, 1003–1014.[Abstract/Free Full Text]

Lafont F, Simons K & Ikonen E. Dissecting the molecular mechanisms of polarized membrane traffic: Reconstitution of three transport steps in epithelial cells using streptolysin-O permeabilization, Cold Spring Harbor Symp Quant Biol, 1995, 60, 753–762.[Abstract/Free Full Text]

Li S, Seitz R & Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases, J Biol Chem, 1996a, 271, 3863–3868.[Abstract/Free Full Text]

Li S, Song KS & Lisanti MP. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes, J Biol Chem, 1996b, 271, 568–573.[Abstract/Free Full Text]

Li S, Song KS, Koh SS, Kikuchi A & Lisanti MP. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells, J Biol Chem, 1996c, 271, 28647–28654.[Abstract/Free Full Text]

Mastick CC, Brady MJ & Saltiel AR. Insulin stimulates the tyrosine phosphorylation of caveolin, J Cell Biol, 1995, 129, 1523–1531.[Abstract/Free Full Text]

Melkonian KA, Chu T, Tortorella LB & Brown DA. Characterization of proteins in detergent-resistant membrane complexes from Madin-Darby canine kidney epithelial cells, Biochemistry, 1995, 34, 16161–16170.[Medline]

Mirre C, Monlauzeur L, Garcia M, Delgrossi M-H & Le Bivic A. Detergent-resistant membrane microdomains from Caco-2 cells do not contain caveolin, Am J Physiol, 1996, 271, C887–C894.[Medline]

Monier S, Parton RG, Vogel F, Behlke J, Henske A & Kurzchalia TV. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro, Mol Biol Cell, 1995, 6, 911–927.[Abstract]

Monier S, Dietzen DJ, Hastings WR, Lublin DM & Kurzchalia TV. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol, FEBS (Fed Eur Biochem Soc) Lett, 1996, 388, 143–149.

Murata M, Peränen J, Schreiner R, Wieland F, Kurzchalia TV & Simons K. VIP21/caveolin is a cholesterol-binding protein, Proc Natl Acad Sci USA, 1995, 92, 10339–10343.[Abstract/Free Full Text]

Müsch A, Xu H, Shields D & Rodriguez-Boulan E. Transport of vesicular stomatitis virus G protein to the cell surface is signal mediated in polarized and nonpolarized cells, J Cell Biol, 1996, 133, 543–558.[Abstract/Free Full Text]

Parton RG, Joggerst B & Simons K. Regulated internalization of caveolae, J Cell Biol, 1994, 127, 1199–1215.[Abstract/Free Full Text]

Parton RG & Simons K. Digging into caveolae, Science, 1995, 269, 2–3.

Peränen J. Rapid affinity-purification and biotinylation of antibodies, Biotechniques, 1992, 13, 546–549.[Medline]

Pimplikar SW & Simons K. Regulation of apical transport in epithelial cells by a Gs class of heterotrimeric G protein, Nature, 1993, 362, 456–458.[Medline]

Pimplikar SW, Ikonen E & Simons K. Basolateral protein transport in streptolysin O-permeabilized MDCK cells, J Cell Biol, 1994, 125, 1025–1035.[Abstract/Free Full Text]

Rothberg KG, Heuser JE, Donzell WC, Ying Y-S, Glenney JR & Anderson RGW. Caveolin, a protein component of caveolae membrane coats, Cell, 1992, 68, 673–682.[Medline]

Sargiacomo M, Sudol M, Tang Z & Lisanti MP. Signal transducing molecules and glycosyl-phosphatidyinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells, J Cell Biol, 1993, 122, 789–807.[Abstract/Free Full Text]

Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC & Lisanti MP. Oligomeric structure of caveolin: implications for caveolae membrane organization, Proc Natl Acad Sci USA, 1995, 92, 9407–9411.[Abstract/Free Full Text]

Scheiffele P, Roth MG & Simons K. Interaction of influenza virus hemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain, EMBO (Eur Mol Biol Organ) J, 1997, 16, 5501–5508.[Medline]

Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF & Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe, J Biol Chem, 1995, 270, 16395–16401.[Abstract/Free Full Text]

Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF & Lisanti MP. Identification, sequence and expression of caveolin-2 defines a caveolin gene family, Proc Natl Acad Sci USA, 1996, 93, 131–135.[Abstract/Free Full Text]

Schnitzer JE, Oh P, Pinney E & Allard J. Filipin-sensitive transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules, J Cell Biol, 1994, 127, 1217–1232.[Abstract/Free Full Text]

Shevchenko A, Keller P, Scheiffele P, Mann M & Simons K. Identification of components of trans-Golgi network-derived transport vesicles and detergent-insoluble complexes by nanoelectrospray tandem mass spectrometry, Electrophoresis, 1997, 18, 2591–2600.[Medline]

Simons K & Ikonen E. Sphingolipid-cholesterol rafts in membrane trafficking and signalling, Nature, 1997, 387, 569–572.[Medline]

Song KS, Tang Z, Li S & Lisanti MP. Mutational analysis of the properties of caveolin-1, J Biol Chem, 1997, 272, 4398–4403.[Abstract/Free Full Text]

Wandinger-Ness A, Bennett MK, Antony C & Simons K. Distinct transport vesicles mediate the delivery of plasma membrane proteins to the apical and basolateral domains of MDCK cells, J Cell Biol, 1990, 111, 987–1000.[Abstract/Free Full Text]

Xu H & Shields D. Prohormone processing in the trans-Golgi network: endoproteolytic cleavage of prosomatostatin and formation of nascent secretory vesicles in permeabilized cells, J Cell Biol, 1993, 122, 1169–1184.[Abstract/Free Full Text]

Zurzolo C, van't Hof W, van Meer G & Rodriguez-Boulan E. VIP21/caveolin, glycosphingolipid clusters and the sorting of glycosylphosphatidylinositol-anchored proteins in epithelial cells, EMBO (Eur Mol Biol Organ) J, 1994, 13, 42–53.[Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Hughes, H., Budnik, A., Schmidt, K., Palmer, K. J., Mantell, J., Noakes, C., Johnson, A., Carter, D. A., Verkade, P., Watson, P., Stephens, D. J. (2009). Organisation of human ER-exit sites: requirements for the localisation of Sec16 to transitional ER. J. Cell Sci. 122: 2924-2934 [Abstract] [Full Text]  
• Mitsui, K., Hatakeyama, K., Matsushita, M., Kanazawa, H. (2009). Saccharomyces cerevisiae Na+/H+ Antiporter Nha1p Associates with Lipid Rafts and Requires Sphingolipid for Stable Localization to the Plasma Membrane. J Biochem 145: 709-720 [Abstract] [Full Text]  
• Paladino, S., Lebreton, S., Tivodar, S., Campana, V., Tempre, R., Zurzolo, C. (2008). Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting. J. Cell Sci. 121: 4001-4007 [Abstract] [Full Text]  
• Langlois, S., Cowan, K. N., Shao, Q., Cowan, B. J., Laird, D. W. (2008). Caveolin-1 and -2 Interact with Connexin43 and Regulate Gap Junctional Intercellular Communication in Keratinocytes. Mol. Biol. Cell 19: 912-928 [Abstract] [Full Text]  
• Boulware, M. I., Kordasiewicz, H., Mermelstein, P. G. (2007). Caveolin Proteins Are Essential for Distinct Effects of Membrane Estrogen Receptors in Neurons. J. Neurosci. 27: 9941-9950 [Abstract] [Full Text]  
• Storey, S. M., Gibbons, T. F., Williams, C. V., Parr, R. D., Schroeder, F., Ball, J. M. (2007). Full-Length, Glycosylated NSP4 Is Localized to Plasma Membrane Caveolae by a Novel Raft Isolation Technique. J. Virol. 81: 5472-5483 [Abstract] [Full Text]  
• Shmuel, M., Nodel-Berner, E., Hyman, T., Rouvinski, A., Altschuler, Y. (2007). Caveolin 2 Regulates Endocytosis and Trafficking of the M1 Muscarinic Receptor in MDCK Epithelial Cells. Mol. Biol. Cell 18: 1570-1585 [Abstract] [Full Text]  
• Dupont, E., Prochiantz, A., Joliot, A. (2007). Identification of a Signal Peptide for Unconventional Secretion. J. Biol. Chem. 282: 8994-9000 [Abstract] [Full Text]  
• Sun, X.-H., Flynn, D. C., Castranova, V., Millecchia, L. L., Beardsley, A. R., Liu, J. (2007). Identification of a Novel Domain at the N Terminus of Caveolin-1 That Controls Rear Polarization of the Protein and Caveolae Formation. J. Biol. Chem. 282: 7232-7241 [Abstract] [Full Text]  
• Reversi, A., Rimoldi, V., Brambillasca, S., Chini, B. (2006). Effects of cholesterol manipulation on the signaling of the human oxytocin receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R861-R869 [Abstract] [Full Text]  
• Browman, D. T., Resek, M. E., Zajchowski, L. D., Robbins, S. M. (2006). Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J. Cell Sci. 119: 3149-3160 [Abstract] [Full Text]  
• Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., Simons, K. (2006). Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA 103: 11172-11177 [Abstract] [Full Text]  
• Murtazina, R., Kovbasnjuk, O., Donowitz, M., Li, X. (2006). Na+/H+ Exchanger NHE3 Activity and Trafficking Are Lipid Raft-dependent. J. Biol. Chem. 281: 17845-17855 [Abstract] [Full Text]  
• Ullrich, N., Caplanusi, A., Brone, B., Hermans, D., Lariviere, E., Nilius, B., Van Driessche, W., Eggermont, J. (2006). Stimulation by caveolin-1 of the hypotonicity-induced release of taurine and ATP at basolateral, but not apical, membrane of Caco-2 cells. Am. J. Physiol. Cell Physiol. 290: C1287-C1296 [Abstract] [Full Text]  
• Parton, R. G., Hanzal-Bayer, M., Hancock, J. F. (2006). Biogenesis of caveolae: a structural model for caveolin-induced domain formation.. J. Cell Sci. 119: 787-796 [Abstract] [Full Text]  
• Mora, R. C., Bonilha, V. L., Shin, B.-C., Hu, J., Cohen-Gould, L., Bok, D., Rodriguez-Boulan, E. (2006). Bipolar assembly of caveolae in retinal pigment epithelium. Am. J. Physiol. Cell Physiol. 290: C832-C843 [Abstract] [Full Text]  
• Orlichenko, L., Huang, B., Krueger, E., McNiven, M. A. (2006). Epithelial Growth Factor-induced Phosphorylation of Caveolin 1 at Tyrosine 14 Stimulates Caveolae Formation in Epithelial Cells. J. Biol. Chem. 281: 4570-4579 [Abstract] [Full Text]  
• Hernandez-Deviez, D. J., Martin, S., Laval, S. H., Lo, H. P., Cooper, S. T., North, K. N., Bushby, K., Parton, R. G. (2006). Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum Mol Genet 15: 129-142 [Abstract] [Full Text]  
• Mehta, D., Malik, A. B. (2006). Signaling Mechanisms Regulating Endothelial Permeability. Physiol. Rev. 86: 279-367 [Abstract] [Full Text]  
• Vagin, O., Turdikulova, S., Sachs, G. (2005). Recombinant Addition of N-Glycosylation Sites to the Basolateral Na,K-ATPase beta1 Subunit Results in Its Clustering in Caveolae and Apical Sorting in HGT-1 Cells. J. Biol. Chem. 280: 43159-43167 [Abstract] [Full Text]  
• Manninen, A., Verkade, P., Le Lay, S., Torkko, J., Kasper, M., Fullekrug, J., Simons, K. (2005). Caveolin-1 Is Not Essential for Biosynthetic Apical Membrane Transport. Mol. Cell. Biol. 25: 10087-10096 [Abstract] [Full Text]  
• Sleight, S. B., Miranda, P. V., Plaskett, N.-W., Maier, B., Lysiak, J., Scrable, H., Herr, J. C., Visconti, P. E. (2005). Isolation and Proteomic Analysis of Mouse Sperm Detergent-Resistant Membrane Fractions: Evidence for Dissociation of Lipid Rafts During Capacitation. Biol. Reprod. 73: 721-729 [Abstract] [Full Text]  
• Tagawa, A., Mezzacasa, A., Hayer, A., Longatti, A., Pelkmans, L., Helenius, A. (2005). Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. JCB 170: 769-779 [Abstract] [Full Text]  
• Vieira, O. V., Verkade, P., Manninen, A., Simons, K. (2005). FAPP2 is involved in the transport of apical cargo in polarized MDCK cells. JCB 170: 521-526 [Abstract] [Full Text]  
• Papanikolaou, A., Papafotika, A., Murphy, C., Papamarcaki, T., Tsolas, O., Drab, M., Kurzchalia, T. V., Kasper, M., Christoforidis, S. (2005). Cholesterol-dependent Lipid Assemblies Regulate the Activity of the Ecto-nucleotidase CD39. J. Biol. Chem. 280: 26406-26414 [Abstract] [Full Text]  
• Delacour, D., Gouyer, V., Zanetta, J.-P., Drobecq, H., Leteurtre, E., Grard, G., Moreau-Hannedouche, O., Maes, E., Pons, A., Andre, S., Le Bivic, A., Gabius, H. J., Manninen, A., Simons, K., Huet, G. (2005). Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. JCB 169: 491-501 [Abstract] [Full Text]  
• Pol, A., Martin, S., Fernandez, M. A., Ingelmo-Torres, M., Ferguson, C., Enrich, C., Parton, R. G. (2005). Cholesterol and Fatty Acids Regulate Dynamic Caveolin Trafficking through the Golgi Complex and between the Cell Surface and Lipid Bodies. Mol. Biol. Cell 16: 2091-2105 [Abstract] [Full Text]  
• Paladino, S., Sarnataro, D., Pillich, R., Tivodar, S., Nitsch, L., Zurzolo, C. (2004). Protein oligomerization modulates raft partitioning and apical sorting of GPI-anchored proteins. JCB 167: 699-709 [Abstract] [Full Text]  
• Pang, S., Urquhart, P., Hooper, N. M. (2004). N-Glycans, not the GPI anchor, mediate the apical targeting of a naturally glycosylated, GPI-anchored protein in polarised epithelial cells. J. Cell Sci. 117: 5079-5086 [Abstract] [Full Text]  
• Ren, X., Ostermeyer, A. G., Ramcharan, L. T., Zeng, Y., Lublin, D. M., Brown, D. A. (2004). Conformational Defects Slow Golgi Exit, Block Oligomerization, and Reduce Raft Affinity of Caveolin-1 Mutant Proteins. Mol. Biol. Cell 15: 4556-4567 [Abstract] [Full Text]  
• Nomura, R., Kiyota, A., Suzaki, E., Kataoka, K., Ohe, Y., Miyamoto, K., Senda, T., Fujimoto, T. (2004). Human Coronavirus 229E Binds to CD13 in Rafts and Enters the Cell through Caveolae. J. Virol. 78: 8701-8708 [Abstract] [Full Text]  
• Kogo, H., Aiba, T., Fujimoto, T. (2004). Cell Type-specific Occurrence of Caveolin-1{alpha} and -1{beta} in the Lung Caused by Expression of Distinct mRNAs. J. Biol. Chem. 279: 25574-25581 [Abstract] [Full Text]  
• Kasahara, K., Nakayama, Y., Ikeda, K., Fukushima, Y., Matsuda, D., Horimoto, S., Yamaguchi, N. (2004). Trafficking of Lyn through the Golgi caveolin involves the charged residues on {alpha}E and {alpha}I helices in the kinase domain. JCB 165: 641-652 [Abstract] [Full Text]  
• Buk, D. M., Waibel, M., Braig, C., Martens, A. S., Heinrich, P. C., Graeve, L. (2004). Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells. J. Cell Sci. 117: 2063-2075 [Abstract] [Full Text]  
• Zhang, H., Links, P. H., Ngsee, J. K., Tran, K., Cui, Z., Ko, K. W. S., Yao, Z. (2004). Localization of Low Density Lipoprotein Receptor-related Protein 1 to Caveolae in 3T3-L1 Adipocytes in Response to Insulin Treatment. J. Biol. Chem. 279: 2221-2230 [Abstract] [Full Text]  
• Delacour, D., Gouyer, V., Leteurtre, E., Ait-Slimane, T., Drobecq, H., Lenoir, C., Moreau-Hannedouche, O., Trugnan, G., Huet, G. (2003). 1-Benzyl-2-acetamido-2-deoxy-{alpha}-D-galactopyranoside Blocks the Apical Biosynthetic Pathway in Polarized HT-29 Cells. J. Biol. Chem. 278: 37799-37809 [Abstract] [Full Text]  
• Kifor, O., Kifor, I., Moore, F. D. Jr., Butters, R. R. Jr., Cantor, T., Gao, P., Brown, E. M. (2003). Decreased Expression of Caveolin-1 and Altered Regulation of Mitogen-Activated Protein Kinase in Cultured Bovine Parathyroid Cells and Human Parathyroid Adenomas. J. Clin. Endocrinol. Metab. 88: 4455-4464 [Abstract] [Full Text]  
• Kifor, O., Kifor, I., Moore, F. D. Jr., Butters, R. R. Jr., Brown, E. M. (2003). m-Calpain Colocalizes with the Calcium-sensing Receptor (CaR) in Caveolae in Parathyroid Cells and Participates in Degradation of the CaR. J. Biol. Chem. 278: 31167-31176 [Abstract] [Full Text]  
• Cho, K. A., Ryu, S. J., Park, J. S., Jang, I. S., Ahn, J. S., Kim, K. T., Park, S. C. (2003). Senescent Phenotype Can Be Reversed by Reduction of Caveolin Status. J. Biol. Chem. 278: 27789-27795 [Abstract] [Full Text]  
• Spitzenberger, F., Pietropaolo, S., Verkade, P., Habermann, B., Lacas-Gervais, S., Mziaut, H., Pietropaolo, M., Solimena, M. (2003). Islet Cell Autoantigen of 69 kDa Is an Arfaptin-related Protein Associated with the Golgi Complex of Insulinoma INS-1 Cells. J. Biol. Chem. 278: 26166-26173 [Abstract] [Full Text]  
• TUMA, P. L., HUBBARD, A. L. (2003). Transcytosis: Crossing Cellular Barriers. Physiol. Rev. 83: 871-932 [Abstract] [Full Text]  
• Wyse, B. D., Prior, I. A., Qian, H., Morrow, I. C., Nixon, S., Muncke, C., Kurzchalia, T. V., Thomas, W. G., Parton, R. G., Hancock, J. F. (2003). Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane. J. Biol. Chem. 278: 23738-23746 [Abstract] [Full Text]  
• Rybin, V. O., Grabham, P. W., Elouardighi, H., Steinberg, S. F. (2003). Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. Am. J. Physiol. Heart Circ. Physiol. 285: H325-H332 [Abstract] [Full Text]  
• Liu, S. M., Cogny, A., Kockx, M., Dean, R. T., Gaus, K., Jessup, W., Kritharides, L. (2003). Cyclodextrins differentially mobilize free and esterified cholesterol from primary human foam cell macrophages. J. Lipid Res. 44: 1156-1166 [Abstract] [Full Text]  
• Sowa, G., Pypaert, M., Fulton, D., Sessa, W. C. (2003). The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc. Natl. Acad. Sci. USA 100: 6511-6516 [Abstract] [Full Text]  
• Kumar, V., Farell, G., Deganello, S., Lieske, J. C. (2003). Annexin II Is Present on Renal Epithelial Cells and Binds Calcium Oxalate Monohydrate Crystals. J. Am. Soc. Nephrol. 14: 289-297 [Abstract] [Full Text]  
• Liu, P., Rudick, M., Anderson, R. G. W. (2002). Multiple Functions of Caveolin-1. J. Biol. Chem. 277: 41295-41298 [Full Text]  
• Brown, G., Rixon, H. W. McL., Sugrue, R. J. (2002). Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J. Gen. Virol. 83: 1841-1850 [Abstract] [Full Text]  
• Sotgia, F., Razani, B., Bonuccelli, G., Schubert, W., Battista, M., Lee, H., Capozza, F., Schubert, A. L., Minetti, C., Buckley, J. T., Lisanti, M. P. (2002). Intracellular Retention of Glycosylphosphatidyl Inositol-Linked Proteins in Caveolin-Deficient Cells. Mol. Cell. Biol. 22: 3905-3926 [Abstract] [Full Text]  
• Garver, W. S., Krishnan, K., Gallagos, J. R., Michikawa, M., Francis, G. A., Heidenreich, R. A. (2002). Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae. J. Lipid Res. 43: 579-589 [Abstract] [Full Text]  
• Alonso, M. A., Millan, J. (2002). The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J. Cell Sci. 114: 3957-3965 [Abstract] [Full Text]  
• Torgersen, M. L., Skretting, G., van Deurs, B., Sandvig, K. (2002). Internalization of cholera toxin by different endocytic mechanisms. J. Cell Sci. 114: 3737-3747 [Abstract] [Full Text]  
• Breuza, L., Corby, S., Arsanto, J.-P., Delgrossi, M.-H., Scheiffele, P., Le Bivic, A. (2002). The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells. J. Cell Sci. 115: 4457-4467 [Abstract] [Full Text]  
• Ramirez, M. I., Pollack, L., Millien, G., Cao, Y. X., Hinds, A., Williams, M. C. (2002). The {alpha}-Isoform of Caveolin-1 Is a Marker of Vasculogenesis in Early Lung Development. J. Histochem. Cytochem. 50: 33-42 [Abstract] [Full Text]  
• Mobius, W., Ohno-Iwashita, Y., van Donselaar, E. G., Oorschot, V. M.J., Shimada, Y., Fujimoto, T., Heijnen, H. F.G., Geuze, H. J., Slot, J. W. (2002). Immunoelectron Microscopic Localization of Cholesterol Using Biotinylated and Non-cytolytic Perfringolysin O. J. Histochem. Cytochem. 50: 43-56 [Abstract] [Full Text]  
• Li, X., Galli, T., Leu, S., Wade, J. B, Weinman, E. J, Leung, G., Cheong, A., Louvard, D., Donowitz, M. (2001). Na+-H+ exchanger 3 (NHE3) is present in lipid rafts in the rabbit ileal brush border: a role for rafts in trafficking and rapid stimulation of NHE3. J. Physiol. 537: 537-552 [Abstract] [Full Text]  
• Bagnat, M., Chang, A., Simons, K. (2001). Plasma Membrane Proton ATPase Pma1p Requires Raft Association for Surface Delivery in Yeast. Mol. Biol. Cell 12: 4129-4138 [Abstract] [Full Text]  
• Sowa, G., Pypaert, M., Sessa, W. C. (2001). Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc. Natl. Acad. Sci. USA 10.1073/pnas.241409998v1 [Abstract] [Full Text]  
• Simons, M., Schwarz, K., Kriz, W., Miettinen, A., Reiser, J., Mundel, P., Holthofer, H. (2001). Involvement of Lipid Rafts in Nephrin Phosphorylation and Organization of the Glomerular Slit Diaphragm. Am. J. Pathol. 159: 1069-1077 [Abstract] [Full Text]  
• Pol, A., Luetterforst, R., Lindsay, M., Heino, S., Ikonen, E., Parton, R. G. (2001). A Caveolin Dominant Negative Mutant Associates with Lipid Bodies and Induces Intracellular Cholesterol Imbalance. JCB 152: 1057-1070 [Abstract] [Full Text]  
• Fujimoto, T., Kogo, H., Ishiguro, K., Tauchi, K., Nomura, R. (2001). Caveolin-2 Is Targeted to Lipid Droplets, a New "Membrane Domain" in the Cell. JCB 152: 1079-1086 [Abstract] [Full Text]  
• Li, H., Brodsky, S., Basco, M., Romanov, V., De Angelis, D. A., Goligorsky, M. S. (2001). Nitric Oxide Attenuates Signal Transduction : Possible Role in Dissociating Caveolin-1 Scaffold. Circ. Res. 88: 229-236 [Abstract] [Full Text]  
• Doyle, D. D., Goings, G., Upshaw-Earley, J., Ambler, S. K., Mondul, A., Palfrey, H. C., Page, E. (2000). Dystrophin Associates With Caveolae of Rat Cardiac Myocytes : Relationship to Dystroglycan. Circ. Res. 87: 480-488 [Abstract] [Full Text]  
• Plant, P. J., Lafont, F., Lecat, S., Verkade, P., Simons, K., Rotin, D. (2000). Apical Membrane Targeting of Nedd4 Is Mediated by an Association of Its C2 Domain with Annexin Xiiib. JCB 149: 1473-1484 [Abstract] [Full Text]  
• Park, H., Go, Y.-M., Darji, R., Choi, J.-W., Lisanti, M. P., Maland, M. C., Jo, H. (2000). Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. Am. J. Physiol. Heart Circ. Physiol. 278: H1285-H1293 [Abstract] [Full Text]  
• Verkade, P., Harder, T., Lafont, F., Simons, K. (2000). Induction of Caveolae in the Apical Plasma Membrane of Madin-Darby Canine Kidney Cells. JCB 148: 727-740 [Abstract] [Full Text]  
• Machleidt, T., Li, W.-P., Liu, P., Anderson, R. G.W. (2000). Multiple Domains in Caveolin-1 Control Its Intracellular Traffic. JCB 148: 17-28 [Abstract] [Full Text]  
• Fujimoto, T, Kogo, H, Nomura, R, Une, T (2000). Isoforms of caveolin-1 and caveolar structure. J. Cell Sci. 113: 3509-3517 [Abstract]  
• Nusrat, A, Parkos, C., Verkade, P, Foley, C., Liang, T., Innis-Whitehouse, W, Eastburn, K., Madara, J. (2000). Tight junctions are membrane microdomains. J. Cell Sci. 113: 1771-1781 [Abstract]  
• Stahlhut, M., van Deurs, B. (2000). Identification of Filamin as a Novel Ligand for Caveolin-1: Evidence for the Organization of Caveolin-1-associated Membrane Domains by the Actin Cytoskeleton. Mol. Biol. Cell 11: 325-337 [Abstract] [Full Text]  
• Ostermeyer, A. G., Beckrich, B. T., Ivarson, K. A., Grove, K. E., Brown, D. A. (1999). Glycosphingolipids Are Not Essential for Formation of Detergent-resistant Membrane Rafts in Melanoma Cells. METHYL-beta -CYCLODEXTRIN DOES NOT AFFECT CELL SURFACE TRANSPORT OF A GPI-ANCHORED PROTEIN. J. Biol. Chem. 274: 34459-34466 [Abstract] [Full Text]  
• Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., Lisanti, M. P. (1999). Caveolins, Liquid-Ordered Domains, and Signal Transduction. Mol. Cell. Biol. 19: 7289-7304 [Full Text]  
• Tugizov, S., Maidji, E., Xiao, J., Pereira, L. (1999). An Acidic Cluster in the Cytosolic Domain of Human Cytomegalovirus Glycoprotein B Is a Signal for Endocytosis from the Plasma Membrane. J. Virol. 73: 8677-8688 [Abstract] [Full Text]  
• Trouet, D., Nilius, B., Jacobs, A., Remacle, C., Droogmans, G., Eggermont, J. (1999). Caveolin-1 modulates the activity of the volume-regulated chloride channel. J. Physiol. 520: 113-119 [Abstract] [Full Text]  
• Mora, R., Bonilha, V. L., Marmorstein, A., Scherer, P. E., Brown, D., Lisanti, M. P., Rodriguez-Boulan, E. (1999). Caveolin-2 Localizes to the Golgi Complex but Redistributes to Plasma Membrane, Caveolae, and Rafts when Co-expressed with Caveolin-1. J. Biol. Chem. 274: 25708-25717 [Abstract] [Full Text]  
• Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwarzler, C., Schwarz, H., Beug, H., Gunthert, U., Huber, L. A. (1999). Analysis of Cd44-Containing Lipid Rafts: Recruitment of Annexin II and Stabilization by the Actin Cytoskeleton. JCB 146: 843-854 [Abstract] [Full Text]  
• Benting, J. H., Rietveld, A. G., Simons, K. (1999). N-Glycans Mediate the Apical Sorting of a Gpi-Anchored, Raft-Associated Protein in Madin-Darby Canine Kidney Cells. JCB 146: 313-320 [Abstract] [Full Text]  
• Luetterforst, R., Stang, E., Zorzi, N., Carozzi, A., Way, M., Parton, R. G. (1999). Molecular Characterization of Caveolin Association with the Golgi Complex: Identification of a Cis-Golgi Targeting Domain in the Caveolin Molecule. JCB 145: 1443-1459 [Abstract] [Full Text]  
• Das, K., Lewis, R. Y., Scherer, P. E., Lisanti, M. P. (1999). The Membrane-spanning Domains of Caveolins-1 and -2 Mediate the Formation of Caveolin Hetero-oligomers. IMPLICATIONS FOR THE ASSEMBLY OF CAVEOLAE MEMBRANES IN VIVO. J. Biol. Chem. 274: 18721-18728 [Abstract] [Full Text]  
• Cheong, K. H., Zacchetti, D., Schneeberger, E. E., Simons, K. (1999). VIP17/MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells. Proc. Natl. Acad. Sci. USA 96: 6241-6248 [Abstract] [Full Text]  
• Lafont, F., Verkade, P., Galli, T., Wimmer, C., Louvard, D., Simons, K. (1999). Raft association of SNAP receptors acting in apical trafficking in Madin-Darby canine kidney cells. Proc. Natl. Acad. Sci. USA 96: 3734-3738 [Abstract] [Full Text]  
• Scheiffele, P., Rietveld, A., Wilk, T., Simons, K. (1999). Influenza Viruses Select Ordered Lipid Domains during Budding from the Plasma Membrane. J. Biol. Chem. 274: 2038-2044 [Abstract] [Full Text]  
• YEAMAN, C., GRINDSTAFF, K. K., NELSON, W. J. (1999). New Perspectives on Mechanisms Involved in Generating Epithelial Cell Polarity. Physiol. Rev. 79: 73-98 [Abstract] [Full Text]  
• Lavie, Y., Fiucci, G., Liscovitch, M. (1998). Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells. J. Biol. Chem. 273: 32380-32383 [Abstract] [Full Text]  
• Lafont, F., Lecat, S., Verkade, P., Simons, K. (1998). Annexin XIIIb Associates with Lipid Microdomains to Function in Apical Delivery. JCB 142: 1413-1427 [Abstract] [Full Text]  
• Waugh, M. G., Lawson, D., Tan, S. K., Hsuan, J. J. (1998). Phosphatidylinositol 4-Phosphate Synthesis in Immunoisolated Caveolae-like Vesicles and Low Buoyant Density Non-caveolar Membranes. J. Biol. Chem. 273: 17115-17121 [Abstract] [Full Text]  
• Peiro, S., Comella, J. X., Enrich, C., Martin-Zanca, D., Rocamora, N. (2000). PC12 Cells Have Caveolae That Contain TrkA. CAVEOLAE-DISRUPTING DRUGS INHIBIT NERVE GROWTH FACTOR-INDUCED, BUT NOT EPIDERMAL GROWTH FACTOR-INDUCED, MAPK PHOSPHORYLATION. J. Biol. Chem. 275: 37846-37852 [Abstract] [Full Text]  
• Schreiber, S., Fleischer, J., Breer, H., Boekhoff, I. (2000). A Possible Role for Caveolin as a Signaling Organizer in Olfactory Sensory Membranes. J. Biol. Chem. 275: 24115-24123 [Abstract] [Full Text]  
• Schlegel, A., Arvan, P., Lisanti, M. P. (2001). Caveolin-1 Binding to Endoplasmic Reticulum Membranes and Entry into the Regulated Secretory Pathway Are Regulated by Serine Phosphorylation. PROTEIN SORTING AT THE LEVEL OF THE ENDOPLASMIC RETICULUM. J. Biol. Chem. 276: 4398-4408 [Abstract] [Full Text]  
• Parat, M.-O., Fox, P. L. (2001). Palmitoylation of Caveolin-1 in Endothelial Cells Is Post-translational but Irreversible. J. Biol. Chem. 276: 15776-15782 [Abstract] [Full Text]  
• del Carmen de Marco, M., Kremer, L., Albar, J. P., Martinez-Menarguez, J. A., Ballesta, J., Garcia-Lopez, M. A., Marazuela, M., Puertollano, R., Alonso, M. A. (2001). BENE, a Novel Raft-associated Protein of the MAL Proteolipid Family, Interacts with Caveolin-1 in Human Endothelial-like ECV304 Cells. J. Biol. Chem. 276: 23009-23017 [Abstract] [Full Text]  
• Park, W.-Y., Park, J.-S., Cho, K.-A, Kim, D.-I., Ko, Y.-G., Seo, J.-S., Park, S. C. (2000). Up-regulation of Caveolin Attenuates Epidermal Growth Factor Signaling in Senescent Cells. J. Biol. Chem. 275: 20847-20852 [Abstract] [Full Text]  
• Sowa, G., Pypaert, M., Sessa, W. C. (2001). Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc. Natl. Acad. Sci. USA 98: 14072-14077 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF, 484K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Scheiffele, P. Articles by Ikonen, E. Search for Related Content PubMed PubMed Citation Articles by Scheiffele, P. Articles by Ikonen, E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Substance via MeSH Social Bookmarking                            What's this?